Interrogating the role of nuclear heparan sulfates in hematopoietic cells
Active Project Grant Awarded Last action
- Award ID
- F31HL184589
- Recipient
-
Albert Einstein College Of Medicine UEI H6N1ZF5HJ2G3
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $50,114
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date 0% complete
- Place of performance
- Bronx, NY 10461, USA
Award details come from USAspending.gov.
Description
- Abstract
- Hematopoiesis involves the self-maintenance and differentiation of hematopoietic stem and progenitor cells (hspcs) through various stages, ultimately yielding terminally differentiated blood cells with diverse morphologies and functions. Our research, along with others, has emphasized the importance of heparan sulfate proteoglycans (hspgs) in this complex process, specifically, the loss of heparan sulfated chains on the proteins to which they are attached disrupts differentiation in hematopoietic stem cells. However, the precise contribution of heparan sulfate (HS) in hematopoietic differentiation is poorly understood. The development of derivatized scfv antibodies targeting unique heparan sulfate epitopes has enabled a quantum leap forward to study this more closely. Interestingly, mass spectrometry and immunofluorescence experiments utilizing these scfv antibodies have revealed the presence of heparan sulfates in distinct subcellular compartments, including the nucleus, challenging the conventional belief that all heparan- sulfated proteins are localized on the cell surface. This unexpected finding aligns with earlier studies suggesting the presence of HS in the nucleus, though the biological significance of these observations has remained elusive. I hypothesize that nuclear HS influence transcriptional programs that guide hematopoietic differentiation. In this work, i will (1) uncover the identity of nuclear heparan-sulfated proteins in hspcs, (2) determine the functional significance of nuclear HS in hspc differentiation, and (3) delineate the mechanisms by which nuclear HS regulates hspc function. Collectively, our proposed studies will have a broad impact on the field by dissecting the functional role of a novel underexplored pathway in hematopoiesis. In the long term, these studies could ultimately open novel avenues for possible therapeutic interventions to treat disorders of the hematopoietic system and other organ systems.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $50,114 |
Quick answers
Who received award F31HL184589?
F31HL184589 was awarded to Albert Einstein College Of Medicine by National Heart Lung and Blood Institute (National Institutes of Health) on January 31, 2027.
How much is award F31HL184589 worth?
$50,114 has been obligated on F31HL184589.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award